Rynse | $5,000,000 | (Jan 30, 2025)
Canvas | $10,000,000 | (Jan 30, 2025)
Leap(INDIA) | $65,000,000 | (Jan 30, 2025)
Certified by Founder
Lodge
Immunai
start up
United States
- New York, NY
- 28/10/2021
- Series B
- $215,000,000
Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
- Industry Biotechnology Research
- Website https://www.immunai.com/
- LinkedIn https://www.linkedin.com/company/immunai/
Intryc (YC S24) | $3,100,000 | (Jan 30, 2025)
D3 | $25,000,000 | (Jan 30, 2025)
Conifers.ai | $25,000,000 | (Jan 30, 2025)
Delfina | $17,000,000 | (Jan 30, 2025)
MSTRO | $1,500,000 | (Jan 30, 2025)
The Helper Bees | $35,000,000 | (Jan 29, 2025)
Applied Labs | $4,200,000 | (Jan 29, 2025)
Atalanta Therapeutics | $75,000,000 | (Jan 29, 2025)
Naboo | $20,828,000 | (Jan 29, 2025)